Seelaus Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$920K Sell
4,957
-50
-1% -$9.28K 0.81% 26
2025
Q1
$1.05M Sell
5,007
-100
-2% -$21K 1% 19
2024
Q4
$908K Buy
5,107
+725
+17% +$129K 0.83% 24
2024
Q3
$865K Buy
4,382
+70
+2% +$13.8K 0.79% 30
2024
Q2
$740K Buy
4,312
+1,130
+36% +$194K 0.75% 32
2024
Q1
$579K Hold
3,182
0.58% 50
2023
Q4
$493K Sell
3,182
-375
-11% -$58.1K 0.48% 71
2023
Q3
$530K Hold
3,557
0.6% 47
2023
Q2
$479K Buy
3,557
+300
+9% +$40.4K 0.38% 94
2023
Q1
$520K Buy
3,257
+557
+21% +$88.9K 0.39% 87
2022
Q4
$436K Hold
2,700
0.33% 97
2022
Q3
$362K Buy
2,700
+250
+10% +$33.5K 0.29% 114
2022
Q2
$375K Hold
2,450
0.28% 115
2022
Q1
$397K Sell
2,450
-650
-21% -$105K 0.24% 130
2021
Q4
$420K Hold
3,100
0.23% 134
2021
Q3
$334K Sell
3,100
-463
-13% -$49.9K 0.2% 165
2021
Q2
$401K Sell
3,563
-571
-14% -$64.3K 0.23% 144
2021
Q1
$447K Buy
4,134
+885
+27% +$95.7K 0.29% 111
2020
Q4
$348K Sell
3,249
-11,176
-77% -$1.2M 0.25% 118
2020
Q3
$1.26M Sell
14,425
-2,251
-13% -$197K 1.02% 31
2020
Q2
$1.64M Buy
16,676
+2,799
+20% +$275K 1.49% 15
2020
Q1
$1.06M Buy
13,877
+10,827
+355% +$825K 1.25% 26
2019
Q4
$270K Sell
3,050
-2,119
-41% -$188K 0.22% 125
2019
Q3
$391K Buy
+5,169
New +$391K 0.34% 88
2018
Q3
Sell
-2,300
Closed -$213K 179
2018
Q2
$213K Hold
2,300
0.19% 145
2018
Q1
$218K Hold
2,300
0.19% 145
2017
Q4
$222K Buy
+2,300
New +$222K 0.19% 151